Green Thumb Industries Inc.
Green Thumb Industries Inc. (GTII.CN) Stock Competitors & Peer Comparison
See (GTII.CN) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| GTII.CN | CA$8.88 | +12.83% | 2.1B | 13.25 | CA$0.67 | N/A |
| CURA.CN | CA$5.22 | +9.21% | 4.1B | -6.07 | -CA$0.86 | N/A |
| BHC.TO | CA$7.52 | +7.12% | 2.8B | 12.97 | CA$0.58 | N/A |
| CURA.TO | CA$3.00 | +13.64% | 2.3B | -6.82 | -CA$0.44 | N/A |
| VRNO.CN | CA$6.32 | +6.76% | 2.2B | -5.40 | -CA$1.17 | N/A |
| CRON.TO | CA$3.52 | +3.53% | 1.3B | -117.33 | -CA$0.03 | N/A |
| TRUL.CN | CA$7.73 | +9.65% | 1.3B | -9.66 | -CA$0.80 | N/A |
| TLRY.TO | CA$8.97 | +7.43% | 908.2M | -0.27 | -CA$32.71 | N/A |
| TER.CN | CA$2.38 | -0.42% | 804.8M | -1.33 | -CA$1.79 | N/A |
| GUD.TO | CA$7.41 | +1.51% | 735.7M | -148.20 | -CA$0.05 | N/A |
Stock Comparison
GTII.CN vs CURA.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, CURA.CN has a market cap of 4.1B. Regarding current trading prices, GTII.CN is priced at CA$8.88, while CURA.CN trades at CA$5.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas CURA.CN's P/E ratio is -6.07. In terms of profitability, GTII.CN's ROE is +0.06%, compared to CURA.CN's ROE of -0.28%. Regarding short-term risk, GTII.CN is more volatile compared to CURA.CN. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check CURA.CN's competition here
GTII.CN vs BHC.TO Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, BHC.TO has a market cap of 2.8B. Regarding current trading prices, GTII.CN is priced at CA$8.88, while BHC.TO trades at CA$7.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas BHC.TO's P/E ratio is 12.97. In terms of profitability, GTII.CN's ROE is +0.06%, compared to BHC.TO's ROE of -0.20%. Regarding short-term risk, GTII.CN is more volatile compared to BHC.TO. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check BHC.TO's competition here
GTII.CN vs CURA.TO Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, CURA.TO has a market cap of 2.3B. Regarding current trading prices, GTII.CN is priced at CA$8.88, while CURA.TO trades at CA$3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas CURA.TO's P/E ratio is -6.82. In terms of profitability, GTII.CN's ROE is +0.06%, compared to CURA.TO's ROE of -0.30%. Regarding short-term risk, GTII.CN is less volatile compared to CURA.TO. This indicates potentially lower risk in terms of short-term price fluctuations for GTII.CN.Check CURA.TO's competition here
GTII.CN vs VRNO.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, VRNO.CN has a market cap of 2.2B. Regarding current trading prices, GTII.CN is priced at CA$8.88, while VRNO.CN trades at CA$6.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas VRNO.CN's P/E ratio is -5.40. In terms of profitability, GTII.CN's ROE is +0.06%, compared to VRNO.CN's ROE of -0.30%. Regarding short-term risk, GTII.CN is more volatile compared to VRNO.CN. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check VRNO.CN's competition here
GTII.CN vs CRON.TO Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, CRON.TO has a market cap of 1.3B. Regarding current trading prices, GTII.CN is priced at CA$8.88, while CRON.TO trades at CA$3.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas CRON.TO's P/E ratio is -117.33. In terms of profitability, GTII.CN's ROE is +0.06%, compared to CRON.TO's ROE of -0.01%. Regarding short-term risk, GTII.CN is more volatile compared to CRON.TO. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check CRON.TO's competition here
GTII.CN vs TRUL.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, TRUL.CN has a market cap of 1.3B. Regarding current trading prices, GTII.CN is priced at CA$8.88, while TRUL.CN trades at CA$7.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas TRUL.CN's P/E ratio is -9.66. In terms of profitability, GTII.CN's ROE is +0.06%, compared to TRUL.CN's ROE of -0.10%. Regarding short-term risk, GTII.CN is more volatile compared to TRUL.CN. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check TRUL.CN's competition here
GTII.CN vs TLRY.TO Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, TLRY.TO has a market cap of 908.2M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while TLRY.TO trades at CA$8.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas TLRY.TO's P/E ratio is -0.27. In terms of profitability, GTII.CN's ROE is +0.06%, compared to TLRY.TO's ROE of -1.06%. Regarding short-term risk, GTII.CN is more volatile compared to TLRY.TO. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check TLRY.TO's competition here
GTII.CN vs TER.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, TER.CN has a market cap of 804.8M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while TER.CN trades at CA$2.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas TER.CN's P/E ratio is -1.33. In terms of profitability, GTII.CN's ROE is +0.06%, compared to TER.CN's ROE of -0.73%. Regarding short-term risk, GTII.CN is more volatile compared to TER.CN. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check TER.CN's competition here
GTII.CN vs GUD.TO Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, GUD.TO has a market cap of 735.7M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while GUD.TO trades at CA$7.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas GUD.TO's P/E ratio is -148.20. In terms of profitability, GTII.CN's ROE is +0.06%, compared to GUD.TO's ROE of -0.01%. Regarding short-term risk, GTII.CN is more volatile compared to GUD.TO. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check GUD.TO's competition here
GTII.CN vs DHT-U.TO Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, DHT-U.TO has a market cap of 674.9M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while DHT-U.TO trades at CA$12.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas DHT-U.TO's P/E ratio is -13.46. In terms of profitability, GTII.CN's ROE is +0.06%, compared to DHT-U.TO's ROE of -0.11%. Regarding short-term risk, GTII.CN is more volatile compared to DHT-U.TO. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check DHT-U.TO's competition here
GTII.CN vs DHT-UN.TO Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, DHT-UN.TO has a market cap of 633.3M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while DHT-UN.TO trades at CA$16.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas DHT-UN.TO's P/E ratio is -13.37. In terms of profitability, GTII.CN's ROE is +0.06%, compared to DHT-UN.TO's ROE of -0.11%. Regarding short-term risk, GTII.CN is more volatile compared to DHT-UN.TO. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check DHT-UN.TO's competition here
GTII.CN vs VRNO.NE Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, VRNO.NE has a market cap of 544.9M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while VRNO.NE trades at CA$1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas VRNO.NE's P/E ratio is -1.52. In terms of profitability, GTII.CN's ROE is +0.06%, compared to VRNO.NE's ROE of -0.30%. Regarding short-term risk, GTII.CN is less volatile compared to VRNO.NE. This indicates potentially lower risk in terms of short-term price fluctuations for GTII.CN.Check VRNO.NE's competition here
GTII.CN vs CPH.TO Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, CPH.TO has a market cap of 463M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while CPH.TO trades at CA$18.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas CPH.TO's P/E ratio is 12.59. In terms of profitability, GTII.CN's ROE is +0.06%, compared to CPH.TO's ROE of +0.24%. Regarding short-term risk, GTII.CN is more volatile compared to CPH.TO. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check CPH.TO's competition here
GTII.CN vs CL.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, CL.CN has a market cap of 418.7M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while CL.CN trades at CA$1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas CL.CN's P/E ratio is -2.35. In terms of profitability, GTII.CN's ROE is +0.06%, compared to CL.CN's ROE of -0.32%. Regarding short-term risk, GTII.CN is less volatile compared to CL.CN. This indicates potentially lower risk in terms of short-term price fluctuations for GTII.CN.Check CL.CN's competition here
GTII.CN vs CCHW.NE Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, CCHW.NE has a market cap of 407.2M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while CCHW.NE trades at CA$1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas CCHW.NE's P/E ratio is -3.52. In terms of profitability, GTII.CN's ROE is +0.06%, compared to CCHW.NE's ROE of -1.07%. Regarding short-term risk, GTII.CN is more volatile compared to CCHW.NE. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check CCHW.NE's competition here
GTII.CN vs TSND.TO Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, TSND.TO has a market cap of 274.6M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while TSND.TO trades at CA$0.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas TSND.TO's P/E ratio is -6.36. In terms of profitability, GTII.CN's ROE is +0.06%, compared to TSND.TO's ROE of -0.73%. Regarding short-term risk, GTII.CN is less volatile compared to TSND.TO. This indicates potentially lower risk in terms of short-term price fluctuations for GTII.CN.Check TSND.TO's competition here
GTII.CN vs ACB.TO Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, ACB.TO has a market cap of 259.7M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while ACB.TO trades at CA$4.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas ACB.TO's P/E ratio is -3.07. In terms of profitability, GTII.CN's ROE is +0.06%, compared to ACB.TO's ROE of -0.01%. Regarding short-term risk, GTII.CN is more volatile compared to ACB.TO. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check ACB.TO's competition here
GTII.CN vs OGI.TO Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, OGI.TO has a market cap of 252.2M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while OGI.TO trades at CA$1.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas OGI.TO's P/E ratio is 12.33. In terms of profitability, GTII.CN's ROE is +0.06%, compared to OGI.TO's ROE of +0.05%. Regarding short-term risk, GTII.CN is more volatile compared to OGI.TO. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check OGI.TO's competition here
GTII.CN vs WEED.TO Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, WEED.TO has a market cap of 239.9M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while WEED.TO trades at CA$1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas WEED.TO's P/E ratio is -0.71. In terms of profitability, GTII.CN's ROE is +0.06%, compared to WEED.TO's ROE of -0.53%. Regarding short-term risk, GTII.CN is more volatile compared to WEED.TO. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check WEED.TO's competition here
GTII.CN vs CCHW.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, CCHW.CN has a market cap of 228.7M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while CCHW.CN trades at CA$0.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas CCHW.CN's P/E ratio is -0.41. In terms of profitability, GTII.CN's ROE is +0.06%, compared to CCHW.CN's ROE of -1.08%. Regarding short-term risk, GTII.CN is more volatile compared to CCHW.CN. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check CCHW.CN's competition here
GTII.CN vs CRDL.TO Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, CRDL.TO has a market cap of 211.1M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while CRDL.TO trades at CA$1.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas CRDL.TO's P/E ratio is -4.61. In terms of profitability, GTII.CN's ROE is +0.06%, compared to CRDL.TO's ROE of -2.18%. Regarding short-term risk, GTII.CN is more volatile compared to CRDL.TO. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check CRDL.TO's competition here
GTII.CN vs TH.TO Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, TH.TO has a market cap of 205.5M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while TH.TO trades at CA$4.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas TH.TO's P/E ratio is -17.19. In terms of profitability, GTII.CN's ROE is +0.06%, compared to TH.TO's ROE of +0.47%. Regarding short-term risk, GTII.CN is more volatile compared to TH.TO. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check TH.TO's competition here
GTII.CN vs XLY.TO Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, XLY.TO has a market cap of 175.3M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while XLY.TO trades at CA$0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas XLY.TO's P/E ratio is 4.33. In terms of profitability, GTII.CN's ROE is +0.06%, compared to XLY.TO's ROE of +0.27%. Regarding short-term risk, GTII.CN is more volatile compared to XLY.TO. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check XLY.TO's competition here
GTII.CN vs CWEB.TO Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, CWEB.TO has a market cap of 162.6M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while CWEB.TO trades at CA$1.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas CWEB.TO's P/E ratio is -5.37. In terms of profitability, GTII.CN's ROE is +0.06%, compared to CWEB.TO's ROE of -1.20%. Regarding short-term risk, GTII.CN is less volatile compared to CWEB.TO. This indicates potentially lower risk in terms of short-term price fluctuations for GTII.CN.Check CWEB.TO's competition here
GTII.CN vs JUSH.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, JUSH.CN has a market cap of 143.6M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while JUSH.CN trades at CA$0.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas JUSH.CN's P/E ratio is -1.59. In terms of profitability, GTII.CN's ROE is +0.06%, compared to JUSH.CN's ROE of +0.89%. Regarding short-term risk, GTII.CN is less volatile compared to JUSH.CN. This indicates potentially lower risk in terms of short-term price fluctuations for GTII.CN.Check JUSH.CN's competition here
GTII.CN vs BHSC.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, BHSC.CN has a market cap of 137.8M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while BHSC.CN trades at CA$7.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas BHSC.CN's P/E ratio is -4.37. In terms of profitability, GTII.CN's ROE is +0.06%, compared to BHSC.CN's ROE of -2.06%. Regarding short-term risk, GTII.CN is more volatile compared to BHSC.CN. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check BHSC.CN's competition here
GTII.CN vs HLS.TO Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, HLS.TO has a market cap of 136.7M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while HLS.TO trades at CA$4.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas HLS.TO's P/E ratio is -8.09. In terms of profitability, GTII.CN's ROE is +0.06%, compared to HLS.TO's ROE of -0.19%. Regarding short-term risk, GTII.CN is more volatile compared to HLS.TO. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check HLS.TO's competition here
GTII.CN vs GRIN.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, GRIN.CN has a market cap of 104.8M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while GRIN.CN trades at CA$0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas GRIN.CN's P/E ratio is 10.50. In terms of profitability, GTII.CN's ROE is +0.06%, compared to GRIN.CN's ROE of +0.28%. Regarding short-term risk, GTII.CN is more volatile compared to GRIN.CN. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check GRIN.CN's competition here
GTII.CN vs MDP.TO Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, MDP.TO has a market cap of 100.8M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while MDP.TO trades at CA$3.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas MDP.TO's P/E ratio is -104.00. In terms of profitability, GTII.CN's ROE is +0.06%, compared to MDP.TO's ROE of -0.00%. Regarding short-term risk, GTII.CN is more volatile compared to MDP.TO. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check MDP.TO's competition here
GTII.CN vs GDNS.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, GDNS.CN has a market cap of 91M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while GDNS.CN trades at CA$0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas GDNS.CN's P/E ratio is -2.74. In terms of profitability, GTII.CN's ROE is +0.06%, compared to GDNS.CN's ROE of -0.46%. Regarding short-term risk, GTII.CN is more volatile compared to GDNS.CN. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check GDNS.CN's competition here
GTII.CN vs PLTH.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, PLTH.CN has a market cap of 68.3M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while PLTH.CN trades at CA$0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas PLTH.CN's P/E ratio is -0.75. In terms of profitability, GTII.CN's ROE is +0.06%, compared to PLTH.CN's ROE of -0.81%. Regarding short-term risk, GTII.CN is less volatile compared to PLTH.CN. This indicates potentially lower risk in terms of short-term price fluctuations for GTII.CN.Check PLTH.CN's competition here
GTII.CN vs TGOD.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, TGOD.CN has a market cap of 62.2M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while TGOD.CN trades at CA$0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas TGOD.CN's P/E ratio is -3.28. In terms of profitability, GTII.CN's ROE is +0.06%, compared to TGOD.CN's ROE of -0.90%. Regarding short-term risk, GTII.CN is more volatile compared to TGOD.CN. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check TGOD.CN's competition here
GTII.CN vs VEXT.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, VEXT.CN has a market cap of 62M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while VEXT.CN trades at CA$0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas VEXT.CN's P/E ratio is -2.50. In terms of profitability, GTII.CN's ROE is +0.06%, compared to VEXT.CN's ROE of -0.23%. Regarding short-term risk, GTII.CN is more volatile compared to VEXT.CN. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check VEXT.CN's competition here
GTII.CN vs BNXT.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, BNXT.CN has a market cap of 59.7M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while BNXT.CN trades at CA$0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas BNXT.CN's P/E ratio is -9.80. In terms of profitability, GTII.CN's ROE is +0.06%, compared to BNXT.CN's ROE of +0.77%. Regarding short-term risk, GTII.CN is more volatile compared to BNXT.CN. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check BNXT.CN's competition here
GTII.CN vs STEM.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, STEM.CN has a market cap of 53.6M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while STEM.CN trades at CA$0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas STEM.CN's P/E ratio is -0.11. In terms of profitability, GTII.CN's ROE is +0.06%, compared to STEM.CN's ROE of -2.75%. Regarding short-term risk, GTII.CN is more volatile compared to STEM.CN. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check STEM.CN's competition here
GTII.CN vs CXXI.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, CXXI.CN has a market cap of 47.2M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while CXXI.CN trades at CA$0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas CXXI.CN's P/E ratio is -10.00. In terms of profitability, GTII.CN's ROE is +0.06%, compared to CXXI.CN's ROE of -0.12%. Regarding short-term risk, GTII.CN is less volatile compared to CXXI.CN. This indicates potentially lower risk in terms of short-term price fluctuations for GTII.CN.Check CXXI.CN's competition here
GTII.CN vs LEEF.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, LEEF.CN has a market cap of 45.3M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while LEEF.CN trades at CA$0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas LEEF.CN's P/E ratio is -2.23. In terms of profitability, GTII.CN's ROE is +0.06%, compared to LEEF.CN's ROE of +1.64%. Regarding short-term risk, GTII.CN is less volatile compared to LEEF.CN. This indicates potentially lower risk in terms of short-term price fluctuations for GTII.CN.Check LEEF.CN's competition here
GTII.CN vs MRMD.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, MRMD.CN has a market cap of 39.8M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while MRMD.CN trades at CA$0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas MRMD.CN's P/E ratio is -1.67. In terms of profitability, GTII.CN's ROE is +0.06%, compared to MRMD.CN's ROE of -0.25%. Regarding short-term risk, GTII.CN is more volatile compared to MRMD.CN. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check MRMD.CN's competition here
GTII.CN vs HEXO.TO Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, HEXO.TO has a market cap of 38.7M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while HEXO.TO trades at CA$0.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas HEXO.TO's P/E ratio is -0.26. In terms of profitability, GTII.CN's ROE is +0.06%, compared to HEXO.TO's ROE of -2.06%. Regarding short-term risk, GTII.CN is more volatile compared to HEXO.TO. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check HEXO.TO's competition here
GTII.CN vs CHM.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, CHM.CN has a market cap of 37.2M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while CHM.CN trades at CA$0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas CHM.CN's P/E ratio is -5.00. In terms of profitability, GTII.CN's ROE is +0.06%, compared to CHM.CN's ROE of +0.78%. Regarding short-term risk, GTII.CN is more volatile compared to CHM.CN. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check CHM.CN's competition here
GTII.CN vs IAN.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, IAN.CN has a market cap of 34.1M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while IAN.CN trades at CA$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas IAN.CN's P/E ratio is -0.50. In terms of profitability, GTII.CN's ROE is +0.06%, compared to IAN.CN's ROE of +0.50%. Regarding short-term risk, GTII.CN is more volatile compared to IAN.CN. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check IAN.CN's competition here
GTII.CN vs INNO.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, INNO.CN has a market cap of 30M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while INNO.CN trades at CA$6.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas INNO.CN's P/E ratio is -5.79. In terms of profitability, GTII.CN's ROE is +0.06%, compared to INNO.CN's ROE of -0.72%. Regarding short-term risk, GTII.CN is more volatile compared to INNO.CN. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check INNO.CN's competition here
GTII.CN vs LABS.TO Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, LABS.TO has a market cap of 29.5M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while LABS.TO trades at CA$0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas LABS.TO's P/E ratio is -2.33. In terms of profitability, GTII.CN's ROE is +0.06%, compared to LABS.TO's ROE of -0.20%. Regarding short-term risk, GTII.CN is less volatile compared to LABS.TO. This indicates potentially lower risk in terms of short-term price fluctuations for GTII.CN.Check LABS.TO's competition here
GTII.CN vs MVMD.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, MVMD.CN has a market cap of 28.2M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while MVMD.CN trades at CA$0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas MVMD.CN's P/E ratio is -4.00. In terms of profitability, GTII.CN's ROE is +0.06%, compared to MVMD.CN's ROE of -4.61%. Regarding short-term risk, GTII.CN is less volatile compared to MVMD.CN. This indicates potentially lower risk in terms of short-term price fluctuations for GTII.CN.Check MVMD.CN's competition here
GTII.CN vs MMEN.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, MMEN.CN has a market cap of 27.7M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while MMEN.CN trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas MMEN.CN's P/E ratio is -0.13. In terms of profitability, GTII.CN's ROE is +0.06%, compared to MMEN.CN's ROE of -0.96%. Regarding short-term risk, GTII.CN is less volatile compared to MMEN.CN. This indicates potentially lower risk in terms of short-term price fluctuations for GTII.CN.Check MMEN.CN's competition here
GTII.CN vs YOUR.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, YOUR.CN has a market cap of 22.9M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while YOUR.CN trades at CA$0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas YOUR.CN's P/E ratio is 8.50. In terms of profitability, GTII.CN's ROE is +0.06%, compared to YOUR.CN's ROE of -1.18%. Regarding short-term risk, GTII.CN is more volatile compared to YOUR.CN. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check YOUR.CN's competition here
GTII.CN vs GWAY.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, GWAY.CN has a market cap of 22.6M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while GWAY.CN trades at CA$0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas GWAY.CN's P/E ratio is -17.00. In terms of profitability, GTII.CN's ROE is +0.06%, compared to GWAY.CN's ROE of -0.02%. Regarding short-term risk, GTII.CN is more volatile compared to GWAY.CN. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check GWAY.CN's competition here
GTII.CN vs MYCO.NE Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, MYCO.NE has a market cap of 21.4M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while MYCO.NE trades at CA$0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas MYCO.NE's P/E ratio is -0.54. In terms of profitability, GTII.CN's ROE is +0.06%, compared to MYCO.NE's ROE of -0.01%. Regarding short-term risk, GTII.CN is more volatile compared to MYCO.NE. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check MYCO.NE's competition here
GTII.CN vs EPIC.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, EPIC.CN has a market cap of 20.6M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while EPIC.CN trades at CA$0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas EPIC.CN's P/E ratio is 8.75. In terms of profitability, GTII.CN's ROE is +0.06%, compared to EPIC.CN's ROE of +0.02%. Regarding short-term risk, GTII.CN is more volatile compared to EPIC.CN. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check EPIC.CN's competition here
GTII.CN vs VIN.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, VIN.CN has a market cap of 20.2M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while VIN.CN trades at CA$0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas VIN.CN's P/E ratio is -0.67. In terms of profitability, GTII.CN's ROE is +0.06%, compared to VIN.CN's ROE of -0.79%. Regarding short-term risk, Volatility data is not available for a full comparison. GTII.CN has daily volatility of 12.52 and VIN.CN has daily volatility of N/A.Check VIN.CN's competition here
GTII.CN vs AVCN.TO Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, AVCN.TO has a market cap of 18.8M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while AVCN.TO trades at CA$0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas AVCN.TO's P/E ratio is -15.00. In terms of profitability, GTII.CN's ROE is +0.06%, compared to AVCN.TO's ROE of -0.68%. Regarding short-term risk, GTII.CN is more volatile compared to AVCN.TO. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check AVCN.TO's competition here
GTII.CN vs AYR-A.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, AYR-A.CN has a market cap of 18.1M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while AYR-A.CN trades at CA$0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas AYR-A.CN's P/E ratio is -0.03. In terms of profitability, GTII.CN's ROE is +0.06%, compared to AYR-A.CN's ROE of -0.65%. Regarding short-term risk, GTII.CN is more volatile compared to AYR-A.CN. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check AYR-A.CN's competition here
GTII.CN vs CBST.NE Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, CBST.NE has a market cap of 17.4M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while CBST.NE trades at CA$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas CBST.NE's P/E ratio is -0.07. In terms of profitability, GTII.CN's ROE is +0.06%, compared to CBST.NE's ROE of +1.89%. Regarding short-term risk, GTII.CN is more volatile compared to CBST.NE. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check CBST.NE's competition here
GTII.CN vs IMCC.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, IMCC.CN has a market cap of 17.2M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while IMCC.CN trades at CA$5.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas IMCC.CN's P/E ratio is -2.68. In terms of profitability, GTII.CN's ROE is +0.06%, compared to IMCC.CN's ROE of -0.41%. Regarding short-term risk, GTII.CN is less volatile compared to IMCC.CN. This indicates potentially lower risk in terms of short-term price fluctuations for GTII.CN.Check IMCC.CN's competition here
GTII.CN vs MRV.TO Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, MRV.TO has a market cap of 15.4M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while MRV.TO trades at CA$1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas MRV.TO's P/E ratio is -19.29. In terms of profitability, GTII.CN's ROE is +0.06%, compared to MRV.TO's ROE of N/A. Regarding short-term risk, GTII.CN is more volatile compared to MRV.TO. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check MRV.TO's competition here
GTII.CN vs RVV.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, RVV.CN has a market cap of 15.2M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while RVV.CN trades at CA$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas RVV.CN's P/E ratio is -1.17. In terms of profitability, GTII.CN's ROE is +0.06%, compared to RVV.CN's ROE of +9.00%. Regarding short-term risk, GTII.CN is more volatile compared to RVV.CN. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check RVV.CN's competition here
GTII.CN vs EXM.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, EXM.CN has a market cap of 15.1M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while EXM.CN trades at CA$0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas EXM.CN's P/E ratio is -0.91. In terms of profitability, GTII.CN's ROE is +0.06%, compared to EXM.CN's ROE of -18.63%. Regarding short-term risk, GTII.CN is more volatile compared to EXM.CN. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check EXM.CN's competition here
GTII.CN vs CHAL.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, CHAL.CN has a market cap of 14.7M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while CHAL.CN trades at CA$0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas CHAL.CN's P/E ratio is -2.25. In terms of profitability, GTII.CN's ROE is +0.06%, compared to CHAL.CN's ROE of +0.00%. Regarding short-term risk, GTII.CN is more volatile compared to CHAL.CN. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check CHAL.CN's competition here
GTII.CN vs LOBE.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, LOBE.CN has a market cap of 14.5M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while LOBE.CN trades at CA$0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas LOBE.CN's P/E ratio is -1.87. In terms of profitability, GTII.CN's ROE is +0.06%, compared to LOBE.CN's ROE of +3.96%. Regarding short-term risk, GTII.CN is more volatile compared to LOBE.CN. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check LOBE.CN's competition here
GTII.CN vs CTX.TO Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, CTX.TO has a market cap of 14M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while CTX.TO trades at CA$0.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas CTX.TO's P/E ratio is 37.00. In terms of profitability, GTII.CN's ROE is +0.06%, compared to CTX.TO's ROE of +0.03%. Regarding short-term risk, GTII.CN is more volatile compared to CTX.TO. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check CTX.TO's competition here
GTII.CN vs RIV.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, RIV.CN has a market cap of 13.7M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while RIV.CN trades at CA$0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas RIV.CN's P/E ratio is -0.21. In terms of profitability, GTII.CN's ROE is +0.06%, compared to RIV.CN's ROE of -0.49%. Regarding short-term risk, GTII.CN is more volatile compared to RIV.CN. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check RIV.CN's competition here
GTII.CN vs PWR.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, PWR.CN has a market cap of 13.5M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while PWR.CN trades at CA$0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas PWR.CN's P/E ratio is 4.50. In terms of profitability, GTII.CN's ROE is +0.06%, compared to PWR.CN's ROE of -0.81%. Regarding short-term risk, GTII.CN is more volatile compared to PWR.CN. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check PWR.CN's competition here
GTII.CN vs ORI.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, ORI.CN has a market cap of 11.7M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while ORI.CN trades at CA$0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas ORI.CN's P/E ratio is -2.11. In terms of profitability, GTII.CN's ROE is +0.06%, compared to ORI.CN's ROE of +0.09%. Regarding short-term risk, GTII.CN is more volatile compared to ORI.CN. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check ORI.CN's competition here
GTII.CN vs TRIP.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, TRIP.CN has a market cap of 10.6M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while TRIP.CN trades at CA$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas TRIP.CN's P/E ratio is -2.50. In terms of profitability, GTII.CN's ROE is +0.06%, compared to TRIP.CN's ROE of -0.30%. Regarding short-term risk, GTII.CN is less volatile compared to TRIP.CN. This indicates potentially lower risk in terms of short-term price fluctuations for GTII.CN.Check TRIP.CN's competition here
GTII.CN vs CNFA.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, CNFA.CN has a market cap of 9.8M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while CNFA.CN trades at CA$0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas CNFA.CN's P/E ratio is -0.83. In terms of profitability, GTII.CN's ROE is +0.06%, compared to CNFA.CN's ROE of -7.84%. Regarding short-term risk, GTII.CN is more volatile compared to CNFA.CN. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check CNFA.CN's competition here
GTII.CN vs OILS.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, OILS.CN has a market cap of 9.3M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while OILS.CN trades at CA$0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas OILS.CN's P/E ratio is 5.50. In terms of profitability, GTII.CN's ROE is +0.06%, compared to OILS.CN's ROE of -0.08%. Regarding short-term risk, GTII.CN is more volatile compared to OILS.CN. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check OILS.CN's competition here
GTII.CN vs VIVO.TO Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, VIVO.TO has a market cap of 9.3M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while VIVO.TO trades at CA$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas VIVO.TO's P/E ratio is -0.16. In terms of profitability, GTII.CN's ROE is +0.06%, compared to VIVO.TO's ROE of -0.78%. Regarding short-term risk, GTII.CN is less volatile compared to VIVO.TO. This indicates potentially lower risk in terms of short-term price fluctuations for GTII.CN.Check VIVO.TO's competition here
GTII.CN vs AVNT.TO Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, AVNT.TO has a market cap of 8.2M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while AVNT.TO trades at CA$0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas AVNT.TO's P/E ratio is -0.82. In terms of profitability, GTII.CN's ROE is +0.06%, compared to AVNT.TO's ROE of -0.35%. Regarding short-term risk, GTII.CN is more volatile compared to AVNT.TO. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check AVNT.TO's competition here
GTII.CN vs CLSH.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, CLSH.CN has a market cap of 8.1M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while CLSH.CN trades at CA$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas CLSH.CN's P/E ratio is 3.50. In terms of profitability, GTII.CN's ROE is +0.06%, compared to CLSH.CN's ROE of +0.03%. Regarding short-term risk, GTII.CN is more volatile compared to CLSH.CN. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check CLSH.CN's competition here
GTII.CN vs AH.TO Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, AH.TO has a market cap of 8.1M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while AH.TO trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas AH.TO's P/E ratio is -0.22. In terms of profitability, GTII.CN's ROE is +0.06%, compared to AH.TO's ROE of -0.58%. Regarding short-term risk, GTII.CN is less volatile compared to AH.TO. This indicates potentially lower risk in terms of short-term price fluctuations for GTII.CN.Check AH.TO's competition here
GTII.CN vs AUSA.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, AUSA.CN has a market cap of 7.8M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while AUSA.CN trades at CA$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas AUSA.CN's P/E ratio is -0.11. In terms of profitability, GTII.CN's ROE is +0.06%, compared to AUSA.CN's ROE of -1.15%. Regarding short-term risk, GTII.CN is more volatile compared to AUSA.CN. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check AUSA.CN's competition here
GTII.CN vs STHZ.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, STHZ.CN has a market cap of 7.7M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while STHZ.CN trades at CA$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas STHZ.CN's P/E ratio is -0.10. In terms of profitability, GTII.CN's ROE is +0.06%, compared to STHZ.CN's ROE of +0.36%. Regarding short-term risk, GTII.CN is more volatile compared to STHZ.CN. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check STHZ.CN's competition here
GTII.CN vs MOJO.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, MOJO.CN has a market cap of 7.5M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while MOJO.CN trades at CA$0.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas MOJO.CN's P/E ratio is -5.36. In terms of profitability, GTII.CN's ROE is +0.06%, compared to MOJO.CN's ROE of -1.22%. Regarding short-term risk, GTII.CN is more volatile compared to MOJO.CN. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check MOJO.CN's competition here
GTII.CN vs CLC.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, CLC.CN has a market cap of 7.4M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while CLC.CN trades at CA$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas CLC.CN's P/E ratio is 3.00. In terms of profitability, GTII.CN's ROE is +0.06%, compared to CLC.CN's ROE of +0.08%. Regarding short-term risk, GTII.CN is more volatile compared to CLC.CN. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check CLC.CN's competition here
GTII.CN vs BBM.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, BBM.CN has a market cap of 7.4M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while BBM.CN trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas BBM.CN's P/E ratio is -1.50. In terms of profitability, GTII.CN's ROE is +0.06%, compared to BBM.CN's ROE of -1.67%. Regarding short-term risk, GTII.CN is more volatile compared to BBM.CN. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check BBM.CN's competition here
GTII.CN vs SPR.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, SPR.CN has a market cap of 7.3M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while SPR.CN trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas SPR.CN's P/E ratio is -0.40. In terms of profitability, GTII.CN's ROE is +0.06%, compared to SPR.CN's ROE of +18.75%. Regarding short-term risk, GTII.CN is more volatile compared to SPR.CN. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check SPR.CN's competition here
GTII.CN vs RWB.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, RWB.CN has a market cap of 7.1M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while RWB.CN trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas RWB.CN's P/E ratio is -0.14. In terms of profitability, GTII.CN's ROE is +0.06%, compared to RWB.CN's ROE of +0.23%. Regarding short-term risk, GTII.CN is less volatile compared to RWB.CN. This indicates potentially lower risk in terms of short-term price fluctuations for GTII.CN.Check RWB.CN's competition here
GTII.CN vs SE.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, SE.CN has a market cap of 6.6M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while SE.CN trades at CA$0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas SE.CN's P/E ratio is 2.43. In terms of profitability, GTII.CN's ROE is +0.06%, compared to SE.CN's ROE of -73.98%. Regarding short-term risk, GTII.CN is more volatile compared to SE.CN. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check SE.CN's competition here
GTII.CN vs HASH.V Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, HASH.V has a market cap of 6.4M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while HASH.V trades at CA$0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas HASH.V's P/E ratio is 0.92. In terms of profitability, GTII.CN's ROE is +0.06%, compared to HASH.V's ROE of +0.14%. Regarding short-term risk, GTII.CN is more volatile compared to HASH.V. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check HASH.V's competition here
GTII.CN vs SNN.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, SNN.CN has a market cap of 6.1M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while SNN.CN trades at CA$0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas SNN.CN's P/E ratio is -0.15. In terms of profitability, GTII.CN's ROE is +0.06%, compared to SNN.CN's ROE of -0.49%. Regarding short-term risk, GTII.CN is more volatile compared to SNN.CN. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check SNN.CN's competition here
GTII.CN vs WLLW.TO Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, WLLW.TO has a market cap of 5.2M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while WLLW.TO trades at CA$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas WLLW.TO's P/E ratio is -0.22. In terms of profitability, GTII.CN's ROE is +0.06%, compared to WLLW.TO's ROE of -0.30%. Regarding short-term risk, GTII.CN is less volatile compared to WLLW.TO. This indicates potentially lower risk in terms of short-term price fluctuations for GTII.CN.Check WLLW.TO's competition here
GTII.CN vs BCBC.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, BCBC.CN has a market cap of 5M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while BCBC.CN trades at CA$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas BCBC.CN's P/E ratio is -2.00. In terms of profitability, GTII.CN's ROE is +0.06%, compared to BCBC.CN's ROE of -1.93%. Regarding short-term risk, GTII.CN is less volatile compared to BCBC.CN. This indicates potentially lower risk in terms of short-term price fluctuations for GTII.CN.Check BCBC.CN's competition here
GTII.CN vs TGIF.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, TGIF.CN has a market cap of 5M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while TGIF.CN trades at CA$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas TGIF.CN's P/E ratio is -0.50. In terms of profitability, GTII.CN's ROE is +0.06%, compared to TGIF.CN's ROE of -0.12%. Regarding short-term risk, GTII.CN is more volatile compared to TGIF.CN. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check TGIF.CN's competition here
GTII.CN vs CANN.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, CANN.CN has a market cap of 4.7M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while CANN.CN trades at CA$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas CANN.CN's P/E ratio is -0.25. In terms of profitability, GTII.CN's ROE is +0.06%, compared to CANN.CN's ROE of -0.66%. Regarding short-term risk, GTII.CN is more volatile compared to CANN.CN. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check CANN.CN's competition here
GTII.CN vs BHNG.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, BHNG.CN has a market cap of 4.7M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while BHNG.CN trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas BHNG.CN's P/E ratio is -1.00. In terms of profitability, GTII.CN's ROE is +0.06%, compared to BHNG.CN's ROE of +4.01%. Regarding short-term risk, GTII.CN is more volatile compared to BHNG.CN. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check BHNG.CN's competition here
GTII.CN vs FFNT.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, FFNT.CN has a market cap of 4.6M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while FFNT.CN trades at CA$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas FFNT.CN's P/E ratio is -0.03. In terms of profitability, GTII.CN's ROE is +0.06%, compared to FFNT.CN's ROE of +7.89%. Regarding short-term risk, GTII.CN is more volatile compared to FFNT.CN. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check FFNT.CN's competition here
GTII.CN vs LUFF.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, LUFF.CN has a market cap of 4M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while LUFF.CN trades at CA$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas LUFF.CN's P/E ratio is -0.56. In terms of profitability, GTII.CN's ROE is +0.06%, compared to LUFF.CN's ROE of -0.32%. Regarding short-term risk, Volatility data is not available for a full comparison. GTII.CN has daily volatility of 12.52 and LUFF.CN has daily volatility of N/A.Check LUFF.CN's competition here
GTII.CN vs FH.NE Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, FH.NE has a market cap of 3.9M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while FH.NE trades at CA$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas FH.NE's P/E ratio is -0.50. In terms of profitability, GTII.CN's ROE is +0.06%, compared to FH.NE's ROE of -2.83%. Regarding short-term risk, GTII.CN is less volatile compared to FH.NE. This indicates potentially lower risk in terms of short-term price fluctuations for GTII.CN.Check FH.NE's competition here
GTII.CN vs BAMM.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, BAMM.CN has a market cap of 3.7M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while BAMM.CN trades at CA$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas BAMM.CN's P/E ratio is -0.12. In terms of profitability, GTII.CN's ROE is +0.06%, compared to BAMM.CN's ROE of +65.27%. Regarding short-term risk, GTII.CN is more volatile compared to BAMM.CN. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check BAMM.CN's competition here
GTII.CN vs TILT.NE Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, TILT.NE has a market cap of 3.5M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while TILT.NE trades at CA$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas TILT.NE's P/E ratio is -0.03. In terms of profitability, GTII.CN's ROE is +0.06%, compared to TILT.NE's ROE of +2.18%. Regarding short-term risk, GTII.CN is more volatile compared to TILT.NE. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check TILT.NE's competition here
GTII.CN vs RMC.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, RMC.CN has a market cap of 3.4M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while RMC.CN trades at CA$0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas RMC.CN's P/E ratio is -4.00. In terms of profitability, GTII.CN's ROE is +0.06%, compared to RMC.CN's ROE of +1.25%. Regarding short-term risk, GTII.CN is more volatile compared to RMC.CN. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check RMC.CN's competition here
GTII.CN vs THC.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, THC.CN has a market cap of 3.3M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while THC.CN trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas THC.CN's P/E ratio is -1.00. In terms of profitability, GTII.CN's ROE is +0.06%, compared to THC.CN's ROE of -0.37%. Regarding short-term risk, GTII.CN is more volatile compared to THC.CN. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check THC.CN's competition here
GTII.CN vs NBUD.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, NBUD.CN has a market cap of 3.2M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while NBUD.CN trades at CA$0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas NBUD.CN's P/E ratio is -1.25. In terms of profitability, GTII.CN's ROE is +0.06%, compared to NBUD.CN's ROE of -0.27%. Regarding short-term risk, GTII.CN is more volatile compared to NBUD.CN. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check NBUD.CN's competition here
GTII.CN vs PLCN.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, PLCN.CN has a market cap of 3.1M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while PLCN.CN trades at CA$0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas PLCN.CN's P/E ratio is -12.00. In terms of profitability, GTII.CN's ROE is +0.06%, compared to PLCN.CN's ROE of +0.03%. Regarding short-term risk, GTII.CN is more volatile compared to PLCN.CN. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check PLCN.CN's competition here
GTII.CN vs MSVN.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, MSVN.CN has a market cap of 2.9M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while MSVN.CN trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas MSVN.CN's P/E ratio is -0.06. In terms of profitability, GTII.CN's ROE is +0.06%, compared to MSVN.CN's ROE of +19.42%. Regarding short-term risk, GTII.CN is more volatile compared to MSVN.CN. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check MSVN.CN's competition here
GTII.CN vs AREV.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, AREV.CN has a market cap of 2.9M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while AREV.CN trades at CA$0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas AREV.CN's P/E ratio is -2.25. In terms of profitability, GTII.CN's ROE is +0.06%, compared to AREV.CN's ROE of +2.76%. Regarding short-term risk, GTII.CN is more volatile compared to AREV.CN. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check AREV.CN's competition here
GTII.CN vs ASP.TO Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, ASP.TO has a market cap of 2.8M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while ASP.TO trades at CA$0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas ASP.TO's P/E ratio is -0.08. In terms of profitability, GTII.CN's ROE is +0.06%, compared to ASP.TO's ROE of +3.10%. Regarding short-term risk, GTII.CN is more volatile compared to ASP.TO. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check ASP.TO's competition here
GTII.CN vs CDVA.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, CDVA.CN has a market cap of 2.7M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while CDVA.CN trades at CA$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas CDVA.CN's P/E ratio is -1.25. In terms of profitability, GTII.CN's ROE is +0.06%, compared to CDVA.CN's ROE of +0.50%. Regarding short-term risk, GTII.CN is more volatile compared to CDVA.CN. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check CDVA.CN's competition here
GTII.CN vs CFT.CN Comparison April 2026
GTII.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTII.CN stands at 2.1B. In comparison, CFT.CN has a market cap of 2.7M. Regarding current trading prices, GTII.CN is priced at CA$8.88, while CFT.CN trades at CA$0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTII.CN currently has a P/E ratio of 13.25, whereas CFT.CN's P/E ratio is -0.13. In terms of profitability, GTII.CN's ROE is +0.06%, compared to CFT.CN's ROE of -2.12%. Regarding short-term risk, GTII.CN is more volatile compared to CFT.CN. This indicates potentially higher risk in terms of short-term price fluctuations for GTII.CN.Check CFT.CN's competition here